- Church & Dwight reported a forecast of adjusted EPS of $0.72 for Q3, falling short of the estimated $0.86.
- Second-quarter net sales totaled $1.51 billion, which is a slight decrease of 0.3% year-on-year but above the estimate of $1.49 billion.
- The Consumer Domestic organic sales decreased by 1%, better than the estimated decrease of 2.26%.
- Specialty Products organic sales saw a slight increase of 0.1%, below the expected growth of 3.84%.
- Overall organic sales growth was 0.1%.
- The company anticipates other expenses of approximately $65 million for the year 2025.
- For the full year 2025, Church & Dwight expects Adjusted EPS growth of between 0% and 2%.
- Projected capital expenditures for 2025 are around $130 million.
- The International Division experienced significant organic growth of 4.8%, attributed to market share gains in all subsidiaries and the global markets group.
- Efforts will be made to enhance investments in strong brands and swiftly tackle opportunities for value creation.
- The company remains confident in its strong operating fundamentals, consistent with its Evergreen model.
- The ongoing tariff impact is around $60 million for a 12-month period, with plans to counteract this through supply chain optimizations and selective pricing adjustments.
- The stock currently holds 10 buy ratings, 10 hold ratings, and 6 sell ratings.
Church & Dwight Co on Smartkarma
Analysts at Baptista Research have provided insightful coverage of Church & Dwight Co on Smartkarma, offering valuable perspectives on the company’s recent performance and strategic direction. In a report titled “Church & Dwight: Focus on Bolt-On Mergers & Acquisitions Seems To Be The Way Forward!” the analysts highlighted the mixed results of the company in the first quarter of 2025. They noted a reduction in organic sales, primarily attributed to retail destocking that posed a significant challenge. The report emphasizes the strategic decisions being made to reposition the company for future growth.
In another report titled “Church & Dwight Co Strikes Back in Fierce Competition—Do They Have A Winning Strategy?” Baptista Research discussed the Q3 2024 results of Church & Dwight Co, Inc. The analysts noted a sales growth of 3.8%, exceeding expectations and indicating strong momentum in key segments. The company’s organic sales also saw a significant increase, driven by volume growth. These reports provide valuable insights for investors looking to understand the performance and potential of Church & Dwight Co in the market.
A look at Church & Dwight Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Church & Dwight Co., Inc. is presented with a mixed bag of Smart Scores according to Smartkarma. While the company receives average ratings for its value and dividend prospects with scores of 2, it shines brighter in terms of growth, resilience, and momentum. With a growth score of 3, Church & Dwight Co. demonstrates potential for expansion and development in the long haul. Furthermore, the company shows resilience with a score of 3, indicating its ability to weather economic uncertainties. Additionally, a momentum score of 3 suggests that Church & Dwight Co. is gaining traction in the market.
Overall, Church & Dwight Co. presents a promising long-term outlook based on its Smart Scores. Despite some average ratings in value and dividend, the company’s strong points lie in its potential for growth, resilience in turbulent times, and the momentum it has been building. As a diversified consumer products company with a range of well-known brands in its portfolio, such as contraceptive products, vitamins, and pregnancy tests, Church & Dwight Co. is positioned to capitalize on evolving consumer needs in the future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
